Furthermore, SDCBP has been identified as the target for the prediction and subsequent treatment of COVID-19 because this protein is involved in the positive regulation of class II HLA, which is significantly increased in patients with less severe forms of the disease [50]. The gene discussed is SDCBP; the disease is COVID-19.